Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT04227249
3 Year Recurrence Free Survival in Ultra-low-risk Endometrial Cancer
Sponsor: Seoul National University Hospital
View on ClinicalTrials.gov
Summary
To verify the safety of omission of lymph node dissection in ultra-low-risk endometrial cancer (KGOG criteria), we examine the survival of women with ultra-low-risk endometrial cancer who do not undergo lymph node dissection
Official title: Three-year Recurrence Free Survival in Patients With Ultra-low-risk Endometrial Cancer Who do Not Undergo Lymph Node dissEction
Key Details
Gender
FEMALE
Age Range
19 Years - Any
Study Type
OBSERVATIONAL
Enrollment
153
Start Date
2020-04
Completion Date
2027-03
Last Updated
2020-01-14
Healthy Volunteers
Not specified
Conditions
Interventions
PROCEDURE
no lymph node dissection
do not undergo lymph node dissection